SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-025465
Filing Date
2022-07-07
Accepted
2022-07-07 17:20:32
Documents
14
Period of Report
2022-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alks-8k_20220707.htm   iXBRL 8-K 58869
2 EX-10.1 alks-ex101_15.htm EX-10.1 119684
3 EX-99.1 alks-ex991_27.htm EX-99.1 12064
  Complete submission text file 0001564590-22-025465.txt   350815

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alks-20220707.xsd EX-101.SCH 5589
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20220707_lab.xml EX-101.LAB 19264
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20220707_pre.xml EX-101.PRE 11462
8 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20220707_htm.xml XML 3525
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 221072325
SIC: 2834 Pharmaceutical Preparations